Steel
Compare Stocks
4 / 10Stock Comparison
ZKIN vs NX vs NUE vs APOG
Revenue, margins, valuation, and 5-year total return — side by side.
Construction
Steel
Construction
ZKIN vs NX vs NUE vs APOG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Steel | Construction | Steel | Construction |
| Market Cap | $8M | $916M | $51.64B | $787M |
| Revenue (TTM) | $179M | $1.85B | $34.16B | $1.40B |
| Net Income (TTM) | $-7M | $-240M | $2.33B | $54M |
| Gross Margin | 5.9% | 26.1% | 14.0% | 22.7% |
| Operating Margin | -2.3% | -10.0% | 10.0% | 6.7% |
| Forward P/E | — | 10.1x | 15.9x | 10.7x |
| Total Debt | $24M | $854M | $7.12B | $286M |
| Cash & Equiv. | $4M | $76M | $2.26B | $40M |
ZKIN vs NX vs NUE vs APOG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| ZK International Gr… (ZKIN) | 100 | 18.1 | -81.9% |
| Quanex Building Pro… (NX) | 100 | 163.3 | +63.3% |
| Nucor Corporation (NUE) | 100 | 538.3 | +438.3% |
| Apogee Enterprises,… (APOG) | 100 | 177.5 | +77.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ZKIN vs NX vs NUE vs APOG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ZKIN lags the leaders in this set but could rank higher in a more targeted comparison.
NX is the clearest fit if your priority is growth exposure.
- Rev growth 43.8%, EPS growth -7.0%, 3Y rev CAGR 14.6%
- 43.8% revenue growth vs ZKIN's -34.2%
NUE carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.
- 426.7% 10Y total return vs NX's 23.7%
- Lower volatility, beta 1.03, Low D/E 32.2%, current ratio 2.94x
- Beta 1.03, yield 1.0%, current ratio 2.94x
- 6.8% margin vs NX's -13.0%
APOG is the #2 pick in this set and the best alternative if income & stability and valuation efficiency is your priority.
- Dividend streak 14 yrs, beta 1.25, yield 2.8%
- PEG 0.32 vs NUE's 0.61
- Lower P/E (10.7x vs 15.9x), PEG 0.32 vs 0.61
- 2.8% yield, 14-year raise streak, vs NUE's 1.0%, (1 stock pays no dividend)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 43.8% revenue growth vs ZKIN's -34.2% | |
| Value | Lower P/E (10.7x vs 15.9x), PEG 0.32 vs 0.61 | |
| Quality / Margins | 6.8% margin vs NX's -13.0% | |
| Stability / Safety | Beta 1.03 vs NX's 1.89, lower leverage | |
| Dividends | 2.8% yield, 14-year raise streak, vs NUE's 1.0%, (1 stock pays no dividend) | |
| Momentum (1Y) | +98.8% vs APOG's -2.8% | |
| Efficiency (ROA) | 6.7% ROA vs NX's -11.7%, ROIC 7.7% vs -8.8% |
ZKIN vs NX vs NUE vs APOG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
ZKIN vs NX vs NUE vs APOG — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NUE leads in 2 of 6 categories
ZKIN leads 0 • NX leads 0 • APOG leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NUE leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NUE is the larger business by revenue, generating $34.2B annually — 190.4x ZKIN's $179M. NUE is the more profitable business, keeping 6.8% of every revenue dollar as net income compared to NX's -13.0%. On growth, NUE holds the edge at +21.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $179M | $1.8B | $34.2B | $1.4B |
| EBITDAEarnings before interest/tax | -$2M | -$81M | $4.9B | $57M |
| Net IncomeAfter-tax profit | -$7M | -$240M | $2.3B | $54M |
| Free Cash FlowCash after capex | $191,770 | $95M | $532M | $95M |
| Gross MarginGross profit ÷ Revenue | +5.9% | +26.1% | +14.0% | +22.7% |
| Operating MarginEBIT ÷ Revenue | -2.3% | -10.0% | +10.0% | +6.7% |
| Net MarginNet income ÷ Revenue | -3.8% | -13.0% | +6.8% | +3.9% |
| FCF MarginFCF ÷ Revenue | +0.1% | +5.1% | +1.6% | +6.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -43.5% | +2.3% | +21.3% | +1.6% |
| EPS Growth (YoY)Latest quarter vs prior year | -19.7% | +71.9% | +3.8% | +6.1% |
Valuation Metrics
Evenly matched — ZKIN and NX and APOG each lead in 2 of 7 comparable metrics.
Valuation Metrics
At 14.5x trailing earnings, APOG trades at a 52% valuation discount to NUE's 30.1x P/E. Adjusting for growth (PEG ratio), APOG offers better value at 0.43x vs NUE's 1.16x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $8M | $916M | $51.6B | $787M |
| Enterprise ValueMkt cap + debt − cash | $28M | $1.7B | $56.5B | $1.0B |
| Trailing P/EPrice ÷ TTM EPS | -2.07x | -3.70x | 30.15x | 14.52x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 10.09x | 15.90x | 10.66x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 1.16x | 0.43x |
| EV / EBITDAEnterprise value multiple | — | — | 13.65x | 21.95x |
| Price / SalesMarket cap ÷ Revenue | 0.12x | 0.50x | 1.59x | 0.56x |
| Price / BookPrice ÷ Book value/share | 0.33x | 1.28x | 2.37x | 1.53x |
| Price / FCFMarket cap ÷ FCF | 42.93x | 8.96x | — | 8.27x |
Profitability & Efficiency
Evenly matched — NUE and APOG each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
APOG delivers a 10.8% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-30 for NX. NUE carries lower financial leverage with a 0.32x debt-to-equity ratio, signaling a more conservative balance sheet compared to NX's 1.18x. On the Piotroski fundamental quality scale (0–9), NUE scores 7/9 vs ZKIN's 3/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -25.1% | -30.2% | +10.6% | +10.8% |
| ROA (TTM)Return on assets | -9.3% | -11.7% | +6.7% | +4.8% |
| ROICReturn on invested capital | -4.4% | -8.8% | +7.7% | +8.1% |
| ROCEReturn on capital employed | -8.2% | -10.4% | +8.9% | +9.7% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 4 | 7 | 7 |
| Debt / EquityFinancial leverage | 0.96x | 1.18x | 0.32x | 0.56x |
| Net DebtTotal debt minus cash | $20M | $778M | $4.9B | $247M |
| Cash & Equiv.Liquid assets | $4M | $76M | $2.3B | $40M |
| Total DebtShort + long-term debt | $24M | $854M | $7.1B | $286M |
| Interest CoverageEBIT ÷ Interest expense | -2.31x | -3.30x | 29.72x | 5.97x |
Total Returns (Dividends Reinvested)
NUE leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NUE five years ago would be worth $24,001 today (with dividends reinvested), compared to $380 for ZKIN. Over the past 12 months, NUE leads with a +98.8% total return vs APOG's -2.8%. The 3-year compound annual growth rate (CAGR) favors NUE at 18.1% vs ZKIN's -34.0% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -5.8% | +31.1% | +34.2% | -1.3% |
| 1-Year ReturnPast 12 months | +28.3% | +23.2% | +98.8% | -2.8% |
| 3-Year ReturnCumulative with dividends | -71.3% | +6.0% | +64.7% | -0.1% |
| 5-Year ReturnCumulative with dividends | -96.2% | -22.0% | +140.0% | +12.9% |
| 10-Year ReturnCumulative with dividends | -97.5% | +23.7% | +426.7% | +10.5% |
| CAGR (3Y)Annualised 3-year return | -34.0% | +2.0% | +18.1% | -0.0% |
Risk & Volatility
Evenly matched — ZKIN and NUE each lead in 1 of 2 comparable metrics.
Risk & Volatility
ZKIN is the less volatile stock with a -0.53 beta — it tends to amplify market swings less than NX's 1.89 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NUE currently trades 96.3% from its 52-week high vs ZKIN's 32.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.58x | 1.83x | 1.01x | 1.25x |
| 52-Week HighHighest price in past year | $4.47 | $22.98 | $235.44 | $49.99 |
| 52-Week LowLowest price in past year | $1.03 | $11.04 | $106.21 | $30.75 |
| % of 52W HighCurrent price vs 52-week peak | +32.4% | +87.3% | +96.3% | +73.2% |
| RSI (14)Momentum oscillator 0–100 | 45.7 | 54.6 | 85.9 | 53.6 |
| Avg Volume (50D)Average daily shares traded | 12K | 458K | 1.4M | 253K |
Analyst Outlook
Evenly matched — NUE and APOG each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: NX as "Hold", NUE as "Buy", APOG as "Hold". Consensus price targets imply 92.7% upside for APOG (target: $71) vs -1.7% for NUE (target: $223). For income investors, APOG offers the higher dividend yield at 2.83% vs NUE's 0.98%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | — | — | $222.83 | $70.50 |
| # AnalystsCovering analysts | — | 10 | 32 | 6 |
| Dividend YieldAnnual dividend ÷ price | — | +1.6% | +1.0% | +2.8% |
| Dividend StreakConsecutive years of raises | — | 0 | 15 | 14 |
| Dividend / ShareAnnual DPS | — | $0.32 | $2.22 | $1.04 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +3.5% | +1.4% | +1.9% |
NUE leads in 2 of 6 categories — strongest in Income & Cash Flow and Total Returns. 4 categories are tied.
ZKIN vs NX vs NUE vs APOG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ZKIN or NX or NUE or APOG a better buy right now?
For growth investors, Quanex Building Products Corporation (NX) is the stronger pick with 43.
8% revenue growth year-over-year, versus -34. 2% for ZK International Group Co. , Ltd. (ZKIN). Apogee Enterprises, Inc. (APOG) offers the better valuation at 14. 5x trailing P/E (10. 7x forward), making it the more compelling value choice. Analysts rate Nucor Corporation (NUE) a "Buy" — based on 32 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ZKIN or NX or NUE or APOG?
On trailing P/E, Apogee Enterprises, Inc.
(APOG) is the cheapest at 14. 5x versus Nucor Corporation at 30. 1x. On forward P/E, Quanex Building Products Corporation is actually cheaper at 10. 1x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Apogee Enterprises, Inc. wins at 0. 32x versus Nucor Corporation's 0. 61x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — ZKIN or NX or NUE or APOG?
Over the past 5 years, Nucor Corporation (NUE) delivered a total return of +140.
0%, compared to -96. 2% for ZK International Group Co. , Ltd. (ZKIN). Over 10 years, the gap is even starker: NUE returned +428. 5% versus ZKIN's -97. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ZKIN or NX or NUE or APOG?
By beta (market sensitivity over 5 years), ZK International Group Co.
, Ltd. (ZKIN) is the lower-risk stock at -0. 58β versus Quanex Building Products Corporation's 1. 83β — meaning NX is approximately -418% more volatile than ZKIN relative to the S&P 500. On balance sheet safety, Nucor Corporation (NUE) carries a lower debt/equity ratio of 32% versus 118% for Quanex Building Products Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — ZKIN or NX or NUE or APOG?
By revenue growth (latest reported year), Quanex Building Products Corporation (NX) is pulling ahead at 43.
8% versus -34. 2% for ZK International Group Co. , Ltd. (ZKIN). On earnings-per-share growth, the picture is similar: Nucor Corporation grew EPS -11. 1% year-over-year, compared to -703. 3% for Quanex Building Products Corporation. Over a 3-year CAGR, NX leads at 14. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ZKIN or NX or NUE or APOG?
Nucor Corporation (NUE) is the more profitable company, earning 5.
4% net margin versus -13. 6% for Quanex Building Products Corporation — meaning it keeps 5. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NUE leads at 8. 2% versus -10. 6% for NX. At the gross margin level — before operating expenses — NX leads at 27. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ZKIN or NX or NUE or APOG more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Apogee Enterprises, Inc. (APOG) is the more undervalued stock at a PEG of 0. 32x versus Nucor Corporation's 0. 61x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Quanex Building Products Corporation (NX) trades at 10. 1x forward P/E versus 15. 9x for Nucor Corporation — 5. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for APOG: 92. 7% to $70. 50.
08Which pays a better dividend — ZKIN or NX or NUE or APOG?
In this comparison, APOG (2.
8% yield), NX (1. 6% yield), NUE (1. 0% yield) pay a dividend. ZKIN does not pay a meaningful dividend and should not be held primarily for income.
09Is ZKIN or NX or NUE or APOG better for a retirement portfolio?
For long-horizon retirement investors, ZK International Group Co.
, Ltd. (ZKIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 58)). Quanex Building Products Corporation (NX) carries a higher beta of 1. 83 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ZKIN: -97. 7%, NX: +24. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ZKIN and NX and NUE and APOG?
These companies operate in different sectors (ZKIN (Basic Materials) and NX (Industrials) and NUE (Basic Materials) and APOG (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: ZKIN is a small-cap quality compounder stock; NX is a small-cap high-growth stock; NUE is a mid-cap quality compounder stock; APOG is a small-cap deep-value stock. NX, NUE, APOG pay a dividend while ZKIN does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.